糖尿病微血管并发症的发病机制及药物治疗的研究进展

doi:10.3969/j.issn.1671-7171.2022.01.029

摘要
图/表
参考文献
相关文章 (15)

[1] JIANG J, LIU Y, CHEN Y, et al. Analysis of changes in retinal thickness in type 2 diabetes without diabetic retinopathy[J].J Diabetes Res,2018, 2018:3082893.
[2] SCOTT A, CHAMBERS D, GOYDER E, et al. Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: A systematic review[J].PLoS One,2017,12(5):e0177210.
[3] LUO Y, LI L, XU X, et al. Decreased circulating bmp-9 levels in patients with type 2 diabetes is a signature of insulin resistance[J].Clin Sci (Lond),2017,131(3):239-246.
[4] WANG R M, WANG Z B, WANG Y, et al. Swiprosin-1 promotes mitochondria-dependent apoptosis of glomerular podocytes via p38 mapk pathway in early-stage diabetic nephropathy[J].Cell Physiol Biochem,2018,45(3):899-916.
[5] WANG T, LI X, FAN L, et al. Negative pressure wound therapy promoted wound healing by suppressing inflammation via down-regulating mapk-jnk signaling pathway in diabetic foot patients[J].Diabetes Res Clin Pract,2019,150(12):81-89.
[6] SMITH-STROM H, IVERSEN M M, GRAUE M, et al. An integrated wound-care pathway, supported by telemedicine, and competent wound management-essential in follow-up care of adults with diabetic foot ulcers[J].Int J Med Inform,2016,94(31):59-66.
[7] QI M, ZHOU Q, ZENG W, et al. Growth factors in the pathogenesis of diabetic foot ulcers[J].Front Biosci (Landmark Ed),2018,23(7):310-317.
[8] ONTARIO H Q. Hyperbaric oxygen therapy for the treatment of diabetic foot ulcers: a health technology assessment[J].Ont Health Technol Assess Ser,2017, 17(5): 1-142.
[9] 何明杰, 甘忠贵, 郑爱甜, 等. 高压氧对糖尿病足创面组织中VEGF、EGF表达水平的影响[J].中国烧伤创疡杂志, 2021, 33(4): 237-242.
[10] SALAMA S E, ELDEEB A E, ELBARBARY A H, et al. Adjuvant hyperbaric oxygen therapy enhances healing of nonischemic diabetic foot ulcers compared with standard wound care alone[J].Int J Low Extrem Wounds,2019, 18(1): 75-80.
[11] 刘庆文, 刘西平, 李萱, 等. 经皮腔内血管成形术在糖尿病足治疗中的应用[J].中华老年心脑血管病杂志, 2012, 14(12): 1248-1251.
[12] 林金加. 经皮血管腔内球囊扩张成形术联合支架置入术治疗糖尿病足的临床效果分析[J].华夏医学, 2021, 34(5): 18-21.
[13] 王明利, 冯琦, 贾一松, 等. 血管腔内成形术治疗对糖尿病足患者创面肉芽组织VEGF/VEGF-R2/SRC表达的影响[J].中国循证心血管医学杂志, 2018, 10(9): 1121-1124.
[14] 吴志昌, 蒋桂勇, 莫捷华. 胫骨横向骨搬移手术治疗糖尿病足效果的影响因素分析[J].中国医药导报, 2021, 18(11): 50-53.
[15] 卢锡钦, 田军. 胫骨横向骨搬移技术再生机制及临床应用的研究进展[J].医学综述, 2021, 27(17): 3450-3455.
[16] 龙能吉, 高志祥, 张少云, 等. 胫骨横向骨搬移技术治疗糖尿病足的临床疗效[J].实用骨科杂志, 2021, 27(5): 452-455.
[17] 赵晓明, 刘亮, 贾中伟, 等. 胫骨横向搬移技术治疗糖尿病足的临床疗效[J].西安交通大学学报(医学版), 2020, 41(2): 244-250.
[18] WENG H B, HAN W K, XIONG Y W, et al. Taxus chinensis ameliorates diabetic nephropathy through down-regulating tgf-beta1/smad pathway[J].Chin J Nat Med,2018,16(2):90-96.
[19] ZHANG X, ZHAO Y, ZHU X, et al. Active vitamin d regulates macrophage m1/m2 phenotypes via the stat-1-trem-1 pathway in diabetic nephropathy[J].J Cell Physiol,2019,234(5):6917-6926.
[20] LU Q, WANG W W, ZHANG M Z, et al. Ros induces epithelial-mesenchymal transition via the tgf-beta1/pi3k/akt/mtor pathway in diabetic nephropathy[J].Exp Ther Med,2019,17(1):835-846.
[21] LIU Z, LIU H, XIAO L, et al. Stc-1 ameliorates renal injury in diabetic nephropathy by inhibiting the expression of bnip3 through the ampk/sirt3 pathway[J].Lab Invest,2019,99(5):684-697.
[22] HUANG S, XU Y, GE X, et al. Long noncoding rna neat1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating akt/mtor signaling pathway[J].J Cell Physiol,2019,234(7):11200-11207.
[23] DONG Z, SUN Y, WEI G, et al. Ergosterol ameliorates diabetic nephropathy by attenuating mesangial cell proliferation and extracellular matrix deposition via the tgf-beta1/smad2 signaling pathway[J].Nutrients,2019,11(2):123-128.
[24] CHEN Y J, KONG L, TANG Z Z, et al. Hesperetin ameliorates diabetic nephropathy in rats by activating nrf2/are/glyoxalase 1 pathway[J].Biomed Pharmacother,2019,111(21):1166-1175.
[25] ZHU L, HAN J, YUAN R, et al. Berberine ameliorates diabetic nephropathy by inhibiting tlr4/nf-kappab pathway[J].Biol Res,2018,51(1):9.
[26] CHENG Y S, CHAO J, CHEN C, et al. The pkcbeta-p66shc-nadph oxidase pathway plays a crucial role in diabetic nephropathy[J].J Pharm Pharmacol,2019,71(3):338-347.
[27] LU L, LU Q, CHEN W, et al. Vitamin d3 protects against diabetic retinopathy by inhibiting high-glucose-induced activation of the ros/txnip/nlrp3 inflammasome pathway[J].J Diabetes Res,2018,2018(12):8193523.
[28] LIU T T, HAO Q, ZHANG Y, et al. Effects of microrna-133b on retinal vascular endothelial cell proliferation and apoptosis through angiotensinogen-mediated angiotensin ii-extracellular signal-regulated kinase 1/2 signalling pathway in rats with diabetic retinopathy[J].Acta Ophthalmol,2018,12(2):223-228.
[29] ZHU S H, LIU B Q, HAO M J, et al. Paeoniflorin suppressed high glucose-induced retinal microglia mmp-9 expression and inflammatory response via inhibition of tlr4/nf-kappab pathway through upregulation of socs3 in diabetic retinopathy[J].Inflammation,2017,40(5):1475-1486.
[30] YANG X, HUO F, LIU B, et al. Crocin inhibits oxidative stress and pro-inflammatory response of microglial cells associated with diabetic retinopathy through the activation of pi3k/akt signaling pathway[J].J Mol Neurosci,2017,61(4):581-589.
[31] CAI X, LI J, WANG M, et al. Glp-1 treatment improves diabetic retinopathy by alleviating autophagy through glp-1r-erk1/2-hdac6 signaling pathway[J].Int J Med Sci,2017,14(12):1203-1212.